ILD: Interstitial lung disease. Proteomics targets the elucidation of the disease mechanisms and detection of new biomarkers for early diagnosis and/or differential diagnosis of a specific disease.

Belimumab is under clinical development by GSK and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, Phase III drugs for Interstitial ...

Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help ...

Drug-induced lung disease cases in France mostly involved ILD, pulmonary edema, and pulmonary fibrosis, largely linked to cancer and CV drugs.

The widespread utilization of chest CT scans has increased the importance of the proper evaluation of incidentally found lung nodules. The primary goal in the evaluation of these nodules is to ...

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer. Metastasis may also be simply referred to as cancer spread. If you have ...

Our LUNG FORCE Heroes inspire, encourage and empower us to raise our voices for lung health. Read about their personal experiences with lung cancer, and become a LUNG FORCE Hero by sharing your story.

The most common finding in chest X-rays is an alveolar filling pattern, usually ipsilateral but it can reach any anatomical portion of the lung parenchyma. These findings usually arise between 2 and 4 ...

Upon relaspe, a confirmatory histopathological sample was obtained from both the right hilum and right lung parenchyma. Fusion testing and DNA sequencing on a previously sampled peritoneal lesion ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...